AZO vs BABA

The Advanced Deterministic Scorecard shows a weak Piotroski F-Score of 4/9, indicating marginal financial health, and the absence of an Altman Z-Score limits distress risk assessment. Despite solid profitability metrics like a 16.94% operating margin and 52.15% gross margin, recent earnings declines and negative earnings surprises over the last four quarters raise concerns. Valuation appears stretched relative to peers with a P/E of 25.77, though below sector average, while insider selling and weakening EPS growth temper bullish sentiment. The stock trades significantly above its intrinsic value estimate of $1,004.92, suggesting substantial premium pricing based on growth expectations.

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.